Recurrent non-small cell lung cancer: Evaluation of CT-guided radiofrequency ablation as salvage therapy Journal Article


Authors: Schoellnast, H.; Deodhar, A.; Hsu, M.; Moskowitz, C.; Nehmeh, S. A.; Thornton, R. H.; Sofocleous, C. T.; Alago, W.; Downey, R. J.; Azzoli, C. G.; Rosenzweig, K. E.; Solomon, S. B.
Article Title: Recurrent non-small cell lung cancer: Evaluation of CT-guided radiofrequency ablation as salvage therapy
Abstract: Background: Radiofrequency ablation (RFA) is a potential application as a salvage tool after failure of surgery, chemotherapy, or radiotherapy of non-small cell lung cancer (NSCLC). Although several studies have evaluated the use of RFA in primary NSCLC, there is little literature on its potential application as a salvage tool. Purpose: To evaluate CT-guided RFA employed as a salvage therapy for pulmonary recurrences of NSCLC after prior treatment with chemotherapy, radiation therapy, and/or surgery. Material and Methods: A retrospective computer database search yielded 33 patients with biopsy proven primary NSCLC who underwent CT-guided RFA of 39 recurrent tumors following surgery, chemotherapy, and/or radiotherapy. Follow-up imaging was performed with CT and PET-CT. The endpoints of interest were progression-free survival (PFS) and time to local progression (TTLP). PFS and TTLP were compared by lesion size (<3 cm, ≥3 cm). Results: The median PFS was 8 months. For patients with a tumor size <3 cm median PFS was 11 months, whereas the median PFS of patients with a tumor size ≥3 cm was 5 months. The difference did not reach statistical significance (P = 0.09). The median TTLP of all tumors was 14 months. TTLP of ablated tumors <3 cm in size was 24 months, compared to 8 months for ablated tumors ≥3 cm in size. The difference did not reach statistical significance (P = 0.07). Conclusion: RFA of recurrent NSCLC may be a valuable salvage tool to achieve local tumor control, especially in tumors measuring <3 cm in size.
Keywords: survival; treatment outcome; aged; aged, 80 and over; disease-free survival; middle aged; survival rate; retrospective studies; disease course; mortality; salvage therapy; disease free survival; chemotherapy; follow up; follow-up studies; progression free survival; computer assisted tomography; neoplasm recurrence, local; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; radiotherapy; tomography, x-ray computed; retrospective study; lung tumor; length of stay; statistical significance; tumors; disease progression; tumor recurrence; surgery; radiography; lung carcinoma; kaplan meier method; medical computing; biological organs; diseases; catheter ablation; surgical equipment; surgery, computer-assisted; tumor size; non small cell lung cancer; percutaneous radiofrequency ablation; kaplan-meier estimate; ablation; potential applications; local tumor control; computer assisted surgery; radio-frequency ablation; local tumor progression; tumor progressions; lesion size; computer database; non-small-cell lung carcinoma; search engines; recurrent tumors
Journal Title: Acta Radiologica
Volume: 53
Issue: 8
ISSN: 0284-1851
Publisher: Sage Publications Ltd.  
Date Published: 2012-10-01
Start Page: 893
End Page: 899
Language: English
DOI: 10.1258/ar.2012.110333
PROVIDER: scopus
PUBMED: 22961644
DOI/URL:
Notes: --- - "Export Date: 2 November 2012" - "CODEN: ACRAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Alago
    25 Alago
  2. Meier Hsu
    169 Hsu
  3. Christopher G Azzoli
    111 Azzoli
  4. Chaya S. Moskowitz
    279 Moskowitz
  5. Ajita Deodhar
    11 Deodhar
  6. Stephen Solomon
    422 Solomon
  7. Sadek Nehmeh
    69 Nehmeh
  8. Robert J Downey
    254 Downey